Adam May

NKTR’s Alopecia Areata Play: Market Misprices Massive Upside

Ok, so I have finally gotten around to writing out my updated thoughts/thesis on $NKTR. Link in this post. I'm about as bullish on the stock now as I've ever been. The document is very long (sorry, but it's free...give me a break). I understand that most people won't read it all. So, if you're only going to read portions of it, don't miss the alopecia areata section. The market has marked this opportunity to zero and I am telling you...the market is wrong to do that. IMO this is a BIG opportunity for $NKTR, no matter how badly the market reacted to the recent data. Yes, IMO the market is getting the atopic dermatitis opportunity and valuation very wrong too, but some people are catching onto that by now...the AA opportunity is just totally (and wrongfully) abandoned. I also think the portion discussing "remittive" data after the AA section is also informative, and it speaks to a potentially massive upside catalyst that nobody is appropriately considering the magnitude of if it hits. Potentially paradigm shifting for one of the largest (if not the largest) indications in all of I&I...very big deal. I often write out long threads with slides and data accompanying my write up. I don't have the time to do that now, but please engage here with thoughts, questions, screenshots from the document, etc. Show me what parts of the thesis interest/excite you, what you don't understand, or even what you think is BS or stupid. It would be great to get some good discourse going on this opportunity, which I have to say I remain very excited about. (Obvious disclaimer here as in the document, yes, I am long and thus biased.) The link below is to the google doc. Totally free. No subscription, no email address, nothing...just a click on a link. https://t.co/DwZTAiyPyp